Neoadjuvant vs. adjuvant treatment of Siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry
about
Risk of subsequent cancer among pediatric, adult and elderly patients following a primary diagnosis of glioblastoma multiforme: a population-based study of the SEER database.Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction.Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
P2860
Neoadjuvant vs. adjuvant treatment of Siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Neoadjuvant vs. adjuvant treat ...... nd end results (SEER) registry
@ast
Neoadjuvant vs. adjuvant treat ...... nd end results (SEER) registry
@en
type
label
Neoadjuvant vs. adjuvant treat ...... nd end results (SEER) registry
@ast
Neoadjuvant vs. adjuvant treat ...... nd end results (SEER) registry
@en
prefLabel
Neoadjuvant vs. adjuvant treat ...... nd end results (SEER) registry
@ast
Neoadjuvant vs. adjuvant treat ...... nd end results (SEER) registry
@en
P2093
P2860
P356
P1476
Neoadjuvant vs. adjuvant treat ...... nd end results (SEER) registry
@en
P2093
Alexander M Stessin
Hannah Yoon
Joseph A Miccio
Minsig Choi
Samuel Ryu
P2860
P304
P356
10.21037/JGO.2015.10.06
P577
2016-06-01T00:00:00Z